SDF-1 and its receptor in the ventricles of rat with monocrotaline-induced pulmonary hypertension

Autor: Veteskova J., Obsivan M., Kmecova Z., Radik M., Srankova J., Malikova E., Klimas J., Krenek P.

Publikováno v: European Pharmaceutical Journal, Vol 65, Iss 2, Pp 23-26 (2018)

Aim: Chemokine stromal cell derived factor-1 (SDF-1) plays an important role in many processes such as apoptosis, proliferation, migration and angiogenesis, and these effects are mediated mostly by the receptor CXCR4. The aim of this study was to det

Externí odkaz: https://doaj.org/article/6ff4cb542398422b8c4dc1b8ed5aaca4

Screening of Patients with Psoriasis for Psoriatic Arthritis in the Slovak Republic

Autor: Urbancek S, Sutka R, Kmecova Z, Salkovska J, Vano I, Pecova T, Rovensky J

Publikováno v: Acta Medica Martiniana, Vol 16, Iss 3, Pp 32-42 (2016)

Global prevalence of psoriasis is ranging from 0.91 % to 8.5 % [1]. Exact numbers are missing for Slovakia. 1-5% range is the most probable while 2 % is also mentioned as an average prevalence for the European population. There is approximately 110 t

Externí odkaz: https://doaj.org/article/a6b813109bca4c629979177caa1d9bd0

Short-term mechanisms activated by NGF to induce pulmonary arterial hyperreactivity

Autor: Bouchet, C., Cardouart, G., Douard, M., Kmecova, Z., Robillard, P., Delcambre, F., Marthan, R., Berger, P., Guibert, C., Freund-Michel, V.

Publikováno v: In Revue des Maladies Respiratoires February 2023 40(2):129-129

Short-term mechanisms activated by the nerve growth factor NGF to induce pulmonary arterial hyperreactivity

Autor: Cardouat, G., Douard, M., Bouchet, C., Kmecová, Z., Robillard, P., Delcambre, F., Marthan, R., Muller, B., Guibert, C., Freund-Michel, V.

Publikováno v: In Revue des Maladies Respiratoires February 2022 39(2):120-120

Pioglitazone restores phosphorylation of downregulated caveolin-1 in right ventricle of monocrotaline-induced pulmonary hypertension.

Autor: Malikova E; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovakia., Kmecova Z; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovakia., Doka G; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovakia., Pivackova LB; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovakia., Balis P; Centre of Experimental Medicine, Slovak Academy of Sciences, Institute of Normal and Pathological Physiology, Bratislava, Slovakia., Trubacova S; Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia., Velasova E; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovakia., Krenek P; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovakia., Klimas J; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovakia.

Publikováno v: Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2022 Feb 17; Vol. 44 (2), pp. 101-112. Date of Electronic Publication: 2021 Nov 07.